Research ArticleClinical Care/Education/Nutrition/Psychosocial Research
Open Access
Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial
Liana K. Billings, Ankur Doshi, Didier Gouet, Alejandra Oviedo, Helena W. Rodbard, Nikolaos Tentolouris, Randi Grøn, Natalie Halladin, Esteban Jodar
DOI: 10.2337/dc17-1114 Published 1 May 2018
Liana K. Billings
1NorthShore University HealthSystem, Evanston, IL
2University of Chicago Pritzker School of Medicine, Chicago, IL
Ankur Doshi
3PrimeCare Medical Group, Houston, TX
Didier Gouet
4La Rochelle Hospital, La Rochelle, France
Alejandra Oviedo
5Santojanni Hospital and Cenudiab, Ciudad Autonoma de Buenos Aires, Argentina
Helena W. Rodbard
6Endocrine and Metabolic Consultants, Rockville, MD
Nikolaos Tentolouris
7Medical School, National and Kapodistrian University of Athens, Athens, Greece
Randi Grøn
8Novo Nordisk A/S, Søborg, Denmark
Natalie Halladin
8Novo Nordisk A/S, Søborg, Denmark
Esteban Jodar
9H. U. QuirónSalud Madrid y Ruber Juan Bravo, Universidad Europea de Madrid, Madrid, Spain